9.00 am – 12.00 pm

Session V: Therapeutic Applications of Gene Editing
Gene Editing for Primary Immunodeficiencies, Suk See DE RAVIN
Optimizing homology-directed repair of DNA breaks in hematopoietic stem cells, Paula CANNON
CRISPR/Cas9 Gene Editing in Primary Human T Cells to Enhance the Efficacy of CAR T Cell Therapy, Crystal MACKALL
Correction of Duchenne Muscular Dystrophy by Genome Editing, Eric OLSON
Gene edited T cell therapies for leukaemia, Waseem QASIM